Total Valuation
Mochida Pharmaceutical Co., Ltd. has a market cap or net worth of €588.28M. The enterprise value is €95.36K.
Market Cap€588.28M
Enterprise Value€95.36K
Share Statistics
Mochida Pharmaceutical Co., Ltd. has 36,390,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,390,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Mochida Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 4.63%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)4.63%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee79.07M
Profits Per Employee5.34M
Employee Count1,479
Asset Turnover0.64
Inventory Turnover1.68
Valuation Ratios
The current PE Ratio of Mochida Pharmaceutical Co., Ltd. is 14.0. Mochida Pharmaceutical Co., Ltd.’s PEG ratio is 0.40.
PE Ratio14.0
PS Ratio1.05
PB Ratio0.87
Price to Fair Value0.87
Price to FCF-12.21
Price to Operating Cash Flow0.00
PEG Ratio0.40
Income Statement
In the last 12 months, Mochida Pharmaceutical Co., Ltd. had revenue of 116.95B and earned 7.90B in profits. Earnings per share was 222.93.
Revenue116.95B
Gross Profit56.26B
Operating Income10.15B
Pretax Income11.17B
Net Income7.90B
EBITDA13.13B
Earnings Per Share (EPS)222.93
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Mochida Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.46
52-Week Price Change-9.58%
50-Day Moving Average16.87
200-Day Moving Average18.09
Relative Strength Index (RSI)47.26
Average Volume (3m)1.00
Important Dates
Mochida Pharmaceutical Co., Ltd. upcoming earnings date is Oct 30, 2026, TBA (Not Confirmed).
Last Earnings DateAug 3, 2026
Next Earnings DateOct 30, 2026
Ex-Dividend Date―
Financial Position
Mochida Pharmaceutical Co., Ltd. as a current ratio of 4.29, with Debt / Equity ratio of 7.13%
Current Ratio4.29
Quick Ratio2.99
Debt to Market Cap0.08
Net Debt to EBITDA-1.38
Interest Coverage Ratio140.94
Taxes
In the past 12 months, Mochida Pharmaceutical Co., Ltd. has paid 3.27B in taxes.
Income Tax3.27B
Effective Tax Rate0.29
Enterprise Valuation
Mochida Pharmaceutical Co., Ltd. EV to EBITDA ratio is 7.97, with an EV/FCF ratio of -10.41.
EV to Sales0.89
EV to EBITDA7.97
EV to Free Cash Flow-10.41
EV to Operating Cash Flow-14.23
Balance Sheet
Mochida Pharmaceutical Co., Ltd. has €31.06B in cash and marketable securities with €10.00B in debt, giving a net cash position of €21.06B billion.
Cash & Marketable Securities€31.06B
Total Debt€10.00B
Net Cash€21.06B
Net Cash Per Share€578.65
Tangible Book Value Per Share€3.93K
Margins
Gross margin is 48.11%, with operating margin of 8.68%, and net profit margin of 6.76%.
Gross Margin48.11%
Operating Margin8.68%
Pretax Margin9.55%
Net Profit Margin6.76%
EBITDA Margin11.22%
EBIT Margin8.68%
Analyst Forecast
The average price target for Mochida Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast4.05%
EPS Growth Forecast30.88%